Repeatability of Scheimpflug Tomography for Assessing Fuchs Endothelial Corneal Dystrophy.


Journal

American journal of ophthalmology
ISSN: 1879-1891
Titre abrégé: Am J Ophthalmol
Pays: United States
ID NLM: 0370500

Informations de publication

Date de publication:
07 2020
Historique:
received: 30 10 2019
revised: 31 01 2020
accepted: 01 02 2020
pubmed: 1 3 2020
medline: 26 9 2020
entrez: 1 3 2020
Statut: ppublish

Résumé

To determine if agreement between subjective interpretations of Scheimpflug tomography maps of corneas with Fuchs endothelial corneal dystrophy (FECD) is affected by daily and hourly changes in corneal edema. Reliability analysis. Scheimpflug imaging pachymetry and posterior elevation maps of corneas with a range of severity of FECD were evaluated in a randomized manner for the presence of 3 tomographic features of edema. Agreement between interpretations of 1 masked observer was assessed (percentage, and κ-statistic with 95% confidence interval) for images taken within minutes on the same day, for images taken at a similar time on a different day, and for images taken over the course of a morning. Intra- and interobserver agreement was also assessed. Interpretations for individual tomographic features agreed for ≥88% of images (κ ≥ 0.75) taken within minutes on the same day; complete disagreement (ie, disagreement for all 3 tomographic features in an image) occurred in ≤3% of images. Interpretations agreed for ≥77% of images (κ ≥ 0.52) taken at a similar time on a different day; complete disagreement did not occur. Interpretations agreed for ≥81% of images (κ ≥ 0.61) taken over the course of a morning; complete disagreement occurred in ≤6% of images. Intraobserver agreement was ≥93% (κ ≥ 0.83) and interobserver agreement was ≥93% (κ ≥ 0.66); complete disagreement did not occur. Subjective interpretation of Scheimpflug images in FECD is highly repeatable for disease classification. Although small variations in interpretations resulted from pathophysiologic changes in corneal hydration and other factors, clinically significant disagreements in interpretation were uncommon and therefore unlikely to affect clinical decision-making.

Identifiants

pubmed: 32112772
pii: S0002-9394(20)30057-X
doi: 10.1016/j.ajo.2020.02.004
pii:
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

91-103

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Sanjay V Patel (SV)

Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: Patel.Sanjay@mayo.edu.

David O Hodge (DO)

Department of Health Sciences Research, Mayo Clinic, Jacksonville, Florida, USA.

Emily J Treichel (EJ)

Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota, USA.

Matthew R Spiegel (MR)

Department of Health Sciences Research, Mayo Clinic, Jacksonville, Florida, USA.

Keith H Baratz (KH)

Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH